VitalHub Reports Second Quarter 2025 Results

Core Insights - VitalHub Corp. reported a significant increase in Annual Recurring Revenue (ARR), which rose by 55% year-over-year to $79.6 million [1][10] - Total revenue for the second quarter of 2025 increased by 47% year-over-year to $23.9 million [1][8] - Adjusted EBITDA also saw a substantial rise, up 50% year-over-year to $6.3 million [1][8] Financial Performance - For the three months ended June 30, 2025, revenue was $23,857,548, compared to $16,237,605 in the same period last year, marking a 47% increase [7][8] - For the six months ended June 30, 2025, total revenue reached $45,532,514, up 45% from $31,494,396 in the prior year [7][8] - Gross profit as a percentage of revenue remained stable at 81% for both Q2 2025 and Q2 2024 [8][9] Growth Drivers - The ARR growth of $28,305,511 or 55% from $51,283,570 at June 30, 2024, was driven by organic growth of $7,329,129 (14%) and acquisition growth of $18,470,000 (36%) [8][10] - The company closed significant acquisitions, including Novari Health and Induction, which are expected to enhance its product offerings in electronic referral and patient engagement solutions [3][8] Cash Position - As of June 30, 2025, VitalHub had a cash balance of $94,008,665, an increase from $56,574,904 at the end of 2024 [10][11] - The company arranged a $15 million loan for acquisition financing, which was fully repaid after the quarter-end [8][10] Strategic Outlook - VitalHub aims to continue its international expansion, supported by a robust cash position and a strong ARR [3][11] - The company is focused on integrating its recent acquisitions to build a consolidated financial profile [3][11]